Humacyte HUMA
NASDAQ HUMA
$0.59 +0.00 (+0.29%)
At close: Nov 11, 2026 · 4:00 PM EST

Humacyte (HUMA) Other Accumulated Expenses (2020 - 2026)

Updated

Humacyte's Other Accumulated Expenses was $185,000 in Q4 2025, down 22.3% from $238,000 a year earlier.

Analysis

Humacyte (HUMA) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

From Q4 2023 onward, Humacyte has reported Other Accumulated Expenses for 5 quarters.

  • In earlier years, Other Accumulated Expenses was $238,000 in FY2024 (+349.1%) and $53,000 in FY2023.
  • Quarterly Other Accumulated Expenses has moved between $53,000 (Q4 2023) and $238,000 (Q4 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Humacyte 163.90 Mn -213.24 Mn -401,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.75 Mn
Jun 30, 2025 61,000.00
Mar 31, 2025 60,000.00
Dec 31, 2024 238,000.00
Dec 31, 2023 53,000.00
Jun 30, 2021 213,475.00
Mar 31, 2021 10,000.00
Dec 31, 2020 34,334.00
Sep 30, 2020 4,334.00
API Access

Humacyte Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=HUMA&period=max&api_key=YOUR_API_KEY